This increased sensitivity means that minor elevations in core body temperature can trigger inappropriate heat-dissipation responses, manifesting as hot flashes
Liraglutide is a GLP-1 agonist, which is the active ingredient in Victoza
Cell density in the basal layer ( f ), stratification ratio ( g , percentage of EdU + suprabasal cells versus total EdU + cells 96 h after EdU pulse) and the proportion of EdU+ basal cells immediately after the 3 h EdU pulse ( h )
And use the 60-day window the way it's designed to be used
Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
Patients with pre-existing diabetic retinopathy should be aware that rapid improvement in blood glucose can sometimes temporarily worsen retinopathy and should report any visual changes promptly